marches42 %Innate Pharma soars 42% in trading session

Innate Pharma soars 42% in trading session

Innate Pharma's stock jumps 42% after outperforming its peers.

Published 1h1 sourceNotable

≈ 15sSpeed

The fact

The stock surpasses the European biotech sector, despite no major news.

This rise contrasts with the volatility seen in biotech stocks.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 17, 2026